Dr. Neal Austin Maler, MD

Dr. Maler practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Maler's NPI, 1497276547, was assigned on June 29, 2017. Dr. Maler graduated from UC Irvine School of Medicine in 2017. Dr. Maler holds California license A158040.

Dr. Maler's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Maler's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Maler to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maler practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Maler's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Maler is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Maler is licensed in California.

Dmand AI lists chronic diabetes, chronic kidney disease, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, gastroenteritis, high cholesterol and hypercalcemia among the conditions Dr. Maler treats.

CMS data shows 661 Medicare services from Dr. Maler across 7 procedure codes in 2024, for 328 Medicare patients. Medicare paid $47,872 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 328 Medicare patients who saw Dr. Maler in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maler's median patient age at 57, with 59% women.

In 2024, Dr. Maler wrote 3,314 Medicare Part D claims for 333 patients. 47% of them were for generic drugs. CMS names the drug for 2,880 of them, across 56 drugs with 11 or more claims each, at $1,157,693 in total drug cost. In 2023, CMS named 1,893 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Maler for performance year 2024, reported through an alternative payment model (APM). Dr. Maler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maler as offering telehealth.

Dmand AI links 1 paper to Dr. Maler in 2016. Dr. Maler's most frequent co-author is Robert G. Bota, MD.

CMS Open Payments shows 19 general payments to Dr. Maler from 8 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 97% of the total. Corcept Therapeutics paid the most, $1,078.

Dr. Maler graduated from UC Irvine School of Medicine in 2017.

Dr. Maler is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.